Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin plus radiotherapy in rectal cancer
IRCT20251226068447N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metformin in rectal cancer and colorectal cancer (CRC) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Improving treatment, Reducing adverse effects of treatment and 2 more. Started Feb 2026; status: completed.
02
Drugs
metformin
03
Conditions
rectal cancercolorectal cancer (CRC)
Beyond the preview
Go deeper on IRCT20251226068447N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251226068447N1.